COOK MEDICAL’s Spectrum antimicrobial-impregnated central venous catheters (CVC) are designed specifically to reduce the likelihood of a catheterrelated bloodstream infection (CRBSI).
The CVC’s combination of minocycline and rifampin has proven to be an effective mixture so far in preventing CRBSIs while simultaneously avoiding antibiotic resistance. Minocycline and rifampin work synergistically to provide broad-spectrum protection against gram-positive, gramnegative and fungal organisms in both short- and long-term use. Unlike most systemic antibiotics, this combination can penetrate the infectious biofilm that forms on all indwelling catheters. Research shows conclusively that use of Spectrum catheters does not promote the growth of antibiotic-resistant strains of bacteria in patients. In a study published in the New England Journal of Medicine, the use of CVCs impregnated with minocycline and rifampin proved to reduce the incidence of CRBSIs to nearly zero.
